| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cyclerion Therapeutics, Inc. (CYCN) has 1 insider with recent SEC Form 4 filings, including 7 buys and 5 sells. CYCN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 25.0K | $80.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2020 | Busch Andreas | Chief Innovation Officer | Buy | 125,000 | $2.53 | $316,250.00 | +96.4% | |
| Nov 6, 2020 | Huyett William | Chief Financial Officer | Sell | 3,827 | $2.52 | $9,644.04 | -5.4% | |
| Feb 21, 2020 | Huyett William | Chief Financial Officer | Sell | 3,559 | $5.12 | $18,222.08 | -4.7% | |
| Dec 30, 2019 | Currie Mark G53 | President | Sell | 50,000 | $2.52 | $125,750.00 | -8.1% | |
| Nov 15, 2019 | Busch Andreas | Chief Innovation Officer | Buy | 125,000 | $1.82 | $227,500.00 | New | |
| Nov 8, 2019 | Huyett William | Chief Financial Officer | Sell | 3,922 | $2.05 | $8,040.10 | -5.0% | |
| Apr 8, 2019 | Schulman Amy W | Director | Buy | 626,117 | $16.00 | $10,017,872.00 | New | |
| Apr 8, 2019 | McGuire Terrance | Director | Buy | 626,117 | $16.00 | $10,017,872.00 | New | |
| Apr 2, 2019 | Currie Mark G53 | President | Buy | 270,107 | $14.81 | $4,000,284.67 | +523.0% |